個案總覽

Supplements the (A) case.

Reports EMC's decision concerning the second shareholder class-action suit and its implications. Legislative efforts to reform securities litigation are also discussed.

Supplements Howard Schultz (A) product # 994006.

Follows the implementation of the corporate identity.

In 1990, Lars Kolind decides to abandon his plan to move Oticon A/S headquarters, but insists on the pursuit of his vision for what he now calls the spaghetti organization--so named because of its relative lack of structure. Shortly after implementation, the company suffers further financial losses. A new managing director, brought in by Kolind, begins to address the financial dynamics of Oticon A/S. Within six months, profitability is restored, and by 1993, the company enjoys its greatest profit since its founding in 1904. Has Kolind achieved the competitive advantage he sought with this new organization? Can the spectacular financial success be attributed to the spaghetti organization? How can the new organization be sustained in the years to come? A 1994 EFMD award winner.

Explores the leveraging of ID resources.

Supplements the (A) case.

Supplements the (A) case.

Supplements the (A) case.

Supplements the (A) case.

Supplements the (A) case.

Supplements the (A) case.

Prosecutors in the U.S. Justice Department's Office of Consumer Litigation reflect on their case against the Beech-Nut Nutrition Corp.

Supplements the (A) case.

Describes how Manville's managers responded when their main product, fiberglass, was classified by an international research agency as a possible human carcinogen.

Describes how the dispute was settled. Designed as a class hand-out.

Supplements the (A) case.

Describes the final decision by CEO Rudi Gassner and the subsequent actions taken by the members of the executive committee.

Describes Beech-Nut's resolution of the apple juice matter.

Officials of the U.S. Food and Drug Administration (FDA) must decide whether to refer the Beech-Nut apple juice case to the Justice Department for criminal prosecution, and if so, whether to recommend prosecution of individual executives or of the company only.